• Publications
  • Influence
Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents
Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra. Attempted replacement of these neurons by stem cells has proved inconclusive. Bone marrow mesenchymalExpand
  • 133
  • 7
[123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease
Parkinsonism in patients taking neuroleptic medications might be induced by dopamine receptor blockade alone or by dopamine blockade with nigrostriatal dysfunction. The differentiation betweenExpand
  • 113
  • 5
Sudden sensorineural hearing loss in multiple sclerosis: clinical course and possible pathogenesis
Hellmann MA, Steiner I, Mosberg‐Galili R. Sudden sensorineural hearing loss in multiple sclerosis: clinical course and possible pathogenesis.
Acta Neurol Scand: 2011: 124: 245–249.
© 2011 John WileyExpand
  • 35
  • 4
Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease
Camptocormia has been described in patients with idiopathic Parkinson's disease (PD). We present a patient with young‐onset PD in whom the disease progressed over 25 years to a crippling state withExpand
  • 56
  • 3
Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy
Finglimod, a sphingosine 1-phosphate receptor modulator, is the first orally administered therapy approved for prophylaxis in multiple sclerosis (MS). Several reports in the last two years suggestedExpand
  • 27
  • 2
  • Open Access
Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study
Background Optic neuritis (ON) in patients with anti-myelin oligodendrocyte glycoprotein (MOG)-IgG antibodies has been associated with a better clinical outcome than anti-aquaporin 4 (AQP4)- IgG ON.Expand
  • 26
  • 2
  • Open Access
Maintenance IVIg therapy in myasthenia gravis does not affect disease activity
OBJECTIVES There is insufficient data on the efficacy of intravenous immunoglobulins (IVIg) as maintenance treatment in myasthenia gravis (MG). We therefore examined response to maintenance IVIgExpand
  • 13
  • 1
Bent knees and tiptoeing: Late manifestations of end‐stage Parkinson's disease
We describe a unique gait phenomenon of bent knees in 9 patients with idiopathic Parkinson disease (mean age, 73.1 ± 11.1 years), 3 of whom also manifested tiptoeing. The bent‐knee posture appearedExpand
  • 23
  • 1
Thoracic sensory level as a false localizing sign in cervical spinal cord and brain lesions
BACKGROUND In rare cases of cervical myelopathy, there may be a discrepancy between the sensory level and the site of cord lesion. This phenomenon is not well recognized. This study sought toExpand
  • 9
  • 1
Focal dystonia as the presenting sign in Creutzfeldt‐Jakob disease
A variety of movement disorders may occur during the course of prion disease. We describe a unique patient who had focal upper limb dystonia as the presenting symptom of familial codon 200Expand
  • 17
  • 1